Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Kindred Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kindred Biosciences Inc market cap is $420.53M.
What is the 52-week high for Kindred Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kindred Biosciences Inc 52 week high is $9.28 as of September 28, 2025.
What is the 52-week low for Kindred Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kindred Biosciences Inc 52 week low is $3.46 as of September 28, 2025.
What is Kindred Biosciences Inc stock price today?
Kindred Biosciences Inc stock price today is $9.25.
What was Kindred Biosciences Inc stock price yesterday?
Kindred Biosciences Inc stock price yesterday was $9.24.
What is the PE ratio of Kindred Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kindred Biosciences Inc’s P/E ratio is -9.02.
What is the Price-to-Book ratio of Kindred Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kindred Biosciences Inc P/B ratio is 5.2691.
What is the 50-day moving average of Kindred Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kindred Biosciences Inc 50-day moving average is $9.19.